- cdc
-
- $3500.00
-
2026-11-19
- CAS:
- Min. Order: 1KG
- Purity: 99.8%
- Supply Ability: 500KG
- CDC
-
- $1.00
-
2026-11-19
- CAS:
- Min. Order: 1G
- Purity: 99.9%
- Supply Ability: 500KG
|
| Product Name: | CDC | | Synonyms: | CINNAMYL-3,4-DIHYDROXY-ALPHA-CYANOCINNAMATE;CDC;(E,Z)-2-Cyano-3-(3,4-dihydroxyphenyl)-2-propenoic acid 3-phenyl-2-propenyl ester;Cinnamyl 3,4-dihydroxy-alpha-cyanocinnamate
CDC;1-Cyclohexy1-3-(3-dimethylamino proply)carbodilimide methiodide;-3,4-dihydroxy-α-cyanocinnamate;2-Propenoic acid, 2-cyano-3-(3,4-dihydroxyphenyl)-, 3-phenyl-2-propen-1-yl ester, (2E)-;Cinnamyl-3,4-dihydroxy-α-cyanocinnamate | | CAS: | 132465-11-3 | | MF: | C19H15NO4 | | MW: | 321.33 | | EINECS: | | | Product Categories: | | | Mol File: | 132465-11-3.mol |  |
| Boiling point | 583.9±50.0 °C(Predicted) | | density | 1.326±0.06 g/cm3(Predicted) | | storage temp. | room temp | | solubility | DMSO: ≥15mg/mL | | form | powder | | pka | 8.75±0.10(Predicted) | | color | light yellow to yellow | | InChI | 1S/C19H15NO4/c20-13-16(11-15-8-9-17(21)18(22)12-15)19(23)24-10-4-7-14-5-2-1-3-6-14/h1-9,11-12,21-22H,10H2/b7-4+,16-11+ | | InChIKey | XGHYFEJMJXGPGN-UYHGDYIZSA-N | | SMILES | Oc1ccc(cc1O)\C=C(/C#N)C(=O)OC\C=C\c2ccccc2 |
| Hazard Codes | Xi,N | | Risk Statements | 43-50/53 | | Safety Statements | 36/37-60-61 | | RIDADR | UN 3077 9 / PGIII | | WGK Germany | 3 | | HazardClass | 9 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Aquatic Acute 1 Aquatic Chronic 1 Skin Sens. 1 |
| Uses | CDC is an inhibitor of 5-LO, 12-LO, and 15-LO. | | Biological Activity | Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent and direct inhibitor of 5-LO (5-Lipoxygenase) th at reduces 5-LO activity in cell-free assays. CDC also inhibits 12-LO and 15-LO | | in vivo | The high glucose and 12(S)-hydroxyeicosatetraenoic acid (HETE) could alter vascular endothelial (VE)-cadherin and β‐catenin phosphorylation levels, but did not alter total protein expression. However, the 12/15-LO inhibitor, Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC), antagonized the effect of high glucose on protein phosphorylation to mitigate destruction of the endothelial cell barrier, and the mouse diabetes mellitus model further confirmed these conclusions[1]. |
| | CDC Preparation Products And Raw materials |
|